..............page:2291-2293
..............page:2323-2326
Present situation of drug safety early warning in China and the solution
li jing-zi~1; jiang bin~1; li yi~1; yu wen-xin~1; shi lu-wen~(1; 2); feng guo-an~3 (1 department of pharmacy administration and clinical pharmacy; college of pharmacy; peking university; beijing 100191; china; 2 international research center of medicinal administration; beijing 100191; china; 3 beijing pharmaceutical association; beijing 100027; china)
..............page:2294-2297
..............page:2382-2392
..............page:2289-2290
..............page:2376-2381
Preparation and evaluation of ophthalmic pH sensitive in-situ gel of acyclovir
li xin-ru~1; lei yao-long~2; shen chuan-yong~3; zhou yan-xia~1; chen xing-wei~1; liu yan~1 (1 department of pharmaceutics; school of pharmaceutical sciences; peking university; beijing 100191; china; 2 state intellectual property office of the people s republic of china; beijing 100088; china; 3 certification center of drug; state food and drug administration; beijing 100061; china)
..............page:2360-2364
Preparation of methotrexate bio-magnetically targeted nanoparticles
hu yan~1; xu wei-ping~2; li jing~3; li jian-ping~1; ma yi-ni~1; yu xiao-li~1 (1 anhui college of traditional chinese medicine; hefei 230038; china; 2 anhui provincial hospital; hefei 230001; china; 3 university of science and technology of china; hefei 230026; china)
..............page:2370-2373
..............page:2320-2322
..............page:2313-2315
Efficacy and safety of Shuangdan Mingmu capsule in treating diabetic retinopathy
tu liang-yu~1; wang wen-chang~2; wang yu-liang~3; zhang ming-liang~4; huang wei-ping~5 (1 the second affiliated hospital of guangzhou university of tcm; guangzhou 510120; china; 2 dongzhimen hospital of beijing university of tcm; beijing 100700; china; 3 affiliated hospital of nanjing university of tcm; nanjing 210029; china; 4 the first affiliated hospital of hunan university of tcm; changsha 410007; china; 5 beijing qihuang limited company of producing drug; beijing 100026; china)
..............page:2331-2336
Control of organic impurities in drugs
su jia-yan~1; yu da-hai~2; ma kun~3 (1 department of pharmacy; the first clinical college; china medical university; shenyang 110001; china; 2 liaoning provincial institue for food and drug control; shenyang 110023; china; 3 center for drug evaluation; state food and drug administration; beijing 100038; china)
..............page:2298-2301,2312
..............page:2306-2308,2315
..............page:2353-2359
Immunosuppressive effect of paclitaxel liposome on B lymphocytes
wang yong-fu~1; chang zhi-fang~2; wang hui~2; li zhan-guo~1 (1 department of rheumatology and immunology; people s hospital; peking university; beijing 100044; china; 2 department of rheumatology and immunology; the affiliated hospital of baotou medical college; baotou 014010; china)
..............page:2345-2348
..............page:2337-2339
..............page:2327-2330
..............page:2340-2344,2348
..............page:2374-2375,2322
..............page:2349-2352,2359
..............page:2302-2305,2319
..............page:2309-2312
..............page:2365-2369
..............page:2316-2319